Filing Details

Accession Number:
0000711377-16-000105
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-23 16:44:03
Reporting Period:
2016-11-22
Filing Date:
2016-11-23
Accepted Time:
2016-11-23 16:44:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-22 21,600 $28.67 144,130 No 4 M Direct
Common Stock Disposition 2016-11-22 21,600 $61.16 122,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2016-11-22 21,600 $0.00 21,600 $28.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
120,121 2017-10-04 No 4 M Direct
Footnotes
  1. The options were granted on 10/4/2012, have five year lives, and vest in equal 20% installments on each of the first five anniversary dates of the grant